Sharecare (SHCR) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sharecare in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SHCR shares.
View SHCR analyst ratings or view top-rated stocks.

3 Wall Street research analysts have issued 12-month target prices for Sharecare's stock. Their SHCR share price forecasts range from $2.00 to $5.00. On average, they expect the company's share price to reach $3.33 in the next year. This suggests a possible upside of 268.1% from the stock's current price.
View analysts price targets for SHCR or view top-rated stocks among Wall Street analysts.

Sharecare's stock was trading at $1.60 at the beginning of the year. Since then, SHCR shares have decreased by 43.4% and is now trading at $0.9055.
View the best growth stocks for 2023 here.

Sharecare saw a decline in short interest in August. As of August 31st, there was short interest totaling 5,600,000 shares, a decline of 31.7% from the August 15th total of 8,200,000 shares. Based on an average daily volume of 1,910,000 shares, the days-to-cover ratio is currently 2.9 days. Currently, 2.0% of the company's shares are short sold.
View Sharecare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our SHCR earnings forecast.

Sharecare, Inc. (NASDAQ:SHCR) announced its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.06) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.06). The firm earned $110.35 million during the quarter, compared to analysts' expectations of $110.13 million. Sharecare had a negative trailing twelve-month return on equity of 15.27% and a negative net margin of 26.11%.

Global X Telemedicine & Digital Health ETF holds 695,960 shares of SHCR stock, representing 0.76% of its portfolio.

Sharecare updated its third quarter 2023 earnings guidance on Thursday, August, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $111.00 million-$113.00 million, compared to the consensus revenue estimate of $112.81 million.

Sharecare trades on the NASDAQ under the ticker symbol "SHCR."

Sharecare's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.35%), Wells Fargo & Company MN (2.18%), State Street Corp (1.88%), Geode Capital Management LLC (1.79%), Samjo Capital LLC (1.73%) and Cowen Prime Advisors LLC (1.64%).
View institutional ownership trends.

Shares of SHCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SHCR stock can currently be purchased for approximately $0.91.

Sharecare (NASDAQ:SHCR) has a market capitalization of $323.38 million and generates $442.42 million in revenue each year. The company earns $-118,710,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis.

The company employs 3,485 workers across the globe.

Sharecare's mailing address is 660 MADISON AVENUE 12TH FLOOR, NEW YORK NY, 10065. The official website for the company is www.sharecare.com. The company can be reached via phone at 404-671-4000 or via email at evan.smith@sharecare.com.